Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002050492-25-000001
Filing Date
2025-05-14
Accepted
2025-05-14 09:26:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5723
  Complete submission text file 0002050492-25-000001.txt   7451
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Subject) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93548 | Film No.: 25943058
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address CALLE SERRANO 37 MADRID U3 28001
Business Address CALLE SERRANO 37 MADRID U3 28001 34917453400
Actyus Private Equity SGIIC, S.A. (Filed by) CIK: 0002050492 (see all company filings)

EIN.: 000000000 | State of Incorp.: U3 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A